| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.02 |